Debiopharm Innovation Fund Investor
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
Invests into
Founded Date:
2012-01-01
Employee Number:
1-10
Technology:
Clinical Decision Support Systems (CDSS)
Investor Type:
Venture Funds
Headquarters:
Lausanne,Vaud,Switzerland,Europe
Number Of Exists:
6
Funding Status:
private
Industry:
Clinical AI